Strides Pharma Intl Company Profile

✉ Email this page to a colleague

STRIDES PHARMA INTL has one hundred and ten approved drugs.

There are five US patents protecting STRIDES PHARMA INTL drugs.

There are ten patent family members on STRIDES PHARMA INTL drugs in eight countries and ninety-five supplementary protection certificates in thirteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma Intl	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	205001-003	Jul 5, 2016		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Strides Pharma Intl	PROPAFENONE HYDROCHLORIDE	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	078540-003	Oct 18, 2010	AB	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Strides Pharma Intl	LYVISPAH	baclofen	GRANULE;ORAL	215422-002	Nov 22, 2021		DISCN	Yes	No	11,850,225	⤷ Start Trial	Y			⤷ Start Trial
Strides Pharma Intl	ROSUVASTATIN CALCIUM	rosuvastatin calcium	TABLET;ORAL	079161-001	Jul 19, 2016		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma Intl	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	6,143,775	⤷ Start Trial
Strides Pharma Intl	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	5,583,152	⤷ Start Trial
Strides Pharma Intl	ACCOLATE	zafirlukast	TABLET;ORAL	020547-003	Sep 17, 1999	5,612,367	⤷ Start Trial
Strides Pharma Intl	ACCOLATE	zafirlukast	TABLET;ORAL	020547-003	Sep 17, 1999	4,859,692	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	10 mg and 20 mg	➤ Subscribe	2008-02-29

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2023055457	⤷ Start Trial
Mexico	2022001139	⤷ Start Trial
European Patent Office	4003323	⤷ Start Trial
Australia	2020323846	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0236940	97C0053	Belgium	⤷ Start Trial	PRODUCT NAME: LETROZOLE; NAT. REGISTRATION NO/DATE: 206 IS 241 F 3 19970616; FIRST REGISTRATION: FR 341 474.2 1996072
0454511	99C0009	Belgium	⤷ Start Trial	PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015
0454436	97C0012	Belgium	⤷ Start Trial	PRODUCT NAME: OLANZAPINE; REGISTRATION NO/DATE: EU/1/96/022/001 19960927
1915993	300625	Netherlands	⤷ Start Trial	PRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.